MLICM
ETNB

Metropolitan Life Insurance Company (MetLife)’s 89bio ETNB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,178
Closed -$48.6K – 704
2024
Q1 		$48.6K Buy
4,178
+344
+9% +$3.81K ﹤0.01% 1418
2023
Q4 		$42.8K Hold
3,834
– – ﹤0.01% 1530
2023
Q3 		$59.2K Buy
3,834
+454
+13% +$7.62K ﹤0.01% 1307
2023
Q2 		$64.1K Buy
+3,380
New +$59.4K ﹤0.01% 1279

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ETNB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of 89bio (ETNB) in Q2 2024, closing a stake of 4,178 shares — an estimated $48.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ETNB in Q2 2023 and held it in 4 quarters. The position peaked at $64.1K in Q2 2023. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,178 89bio shares in Q2 2024, an estimated $48.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in 89bio in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s 89bio position peaked at $64.1K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.